Circulating Immune Checkpoint Panel Results Interpretation Guide

Pathway Analysis

The following sections summarize key co-stimulatory and inhibitory signaling pathways that regulate immune activation, as suggested by the measured analytes. These pathways control the balance between immune activation and suppression, particularly in T cell responses.

Soluble forms of these markers may reflect immune activation status, regulatory feedback mechanisms, or immune exhaustion. These interpretations provide insight into immune system regulation and should be considered alongside clinical findings and other laboratory data.

Canonical CD28–B7 Costimulatory Signaling

Back to top

This pathway reflects activation of primary T cell co-stimulatory signals required for effective immune responses. Engagement of CD28-family receptors by B7 ligands on antigen-presenting cells provides essential signals for T cell activation, proliferation, and survival.

Core Costimulatory Markers

  • CD28 – A key co-stimulatory receptor expressed on T cells that enhances activation following antigen recognition.
  • CD80 (B7-1), CD86 (B7-2) – Ligands expressed on antigen-presenting cells that bind CD28 to initiate T cell activation.
  • ICOS (Inducible T-cell Co-Stimulator) – A co-stimulatory receptor that supports T cell expansion, cytokine production, and differentiation, particularly in helper T cell responses.

Inhibitory Immune Checkpoint Signaling

Back to top

This pathway reflects activation of inhibitory immune checkpoints that regulate immune responses and prevent excessive inflammation or autoimmunity. These pathways function as “brakes” on immune activation and are central to immune tolerance and exhaustion states.

Core Inhibitory Checkpoint Markers

  • CTLA-4 – Competes with CD28 for B7 ligands and inhibits early T cell activation.
  • PD-1 – Suppresses T cell activation and function upon binding its ligands.
  • PD-L1, PD-L2 – Ligands that engage PD-1 to inhibit T cell responses.
  • LAG-3 – Negatively regulates T cell proliferation and activation.
  • TIM-3 – Associated with T cell exhaustion and regulation of immune responses.
  • BTLA – An inhibitory receptor that dampens lymphocyte activation through interaction with HVEM.

TNFR Superfamily Co-Regulatory Signaling

Back to top

This pathway reflects additional co-stimulatory and co-regulatory signals mediated through the tumor necrosis factor receptor (TNFR) superfamily. These signals contribute to T cell survival, differentiation, and immune system coordination.

Core TNFR Superfamily Markers

  • CD27 – Supports T cell expansion and survival following activation.
  • CD40 – Expressed on antigen-presenting cells; critical for T cell–dependent immune responses and B cell activation.
  • GITR (Glucocorticoid-Induced TNFR-Related Protein) – Modulates T cell activation and regulatory T cell function.
  • GITRL – Ligand for GITR, contributing to immune activation and regulation.
  • HVEM – A central co-regulatory molecule that can deliver either activating or inhibitory signals depending on binding partners.

Innate Pattern Recognition–Driven Co-Stimulation

Back to top

This pathway reflects activation of innate immune signaling that contributes to downstream adaptive immune activation. Pattern recognition receptors detect microbial components and initiate immune responses.

Core Innate Activation Marker

  • TLR-2 (Toll-Like Receptor 2) – Recognizes bacterial and fungal components, triggering innate immune activation and promoting downstream co-stimulatory signaling.